Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Prostate Cancer”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Large-scale testing (Phase 3)Looking for participantsNCT06496581
What this trial is testing

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

Who this might be right for
Prostate Cancer Metastatic
UNICANCER 500
Testing effectiveness (Phase 2)Looking for participantsNCT06150417
What this trial is testing

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Who this might be right for
Prostate CancerMalignant Neoplasm of ProstateSecondary Malignant Neoplasm of Prostate
Case Comprehensive Cancer Center 200
Testing effectiveness (Phase 2)Looking for participantsNCT05223803
What this trial is testing

TERPS Trial for de Novo Oligometastic Prostate Cancer

Who this might be right for
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore 122
Large-scale testing (Phase 3)Active Not RecruitingNCT04493853
What this trial is testing

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

Who this might be right for
Hormone-Sensitive Prostate Cancer
AstraZeneca 1,012
Testing effectiveness (Phase 2)Looking for participantsNCT05873192
What this trial is testing

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)Looking for participantsNCT04787744
What this trial is testing

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Who this might be right for
Prostate CancerOligometastasisOligorecurrence+3 more
VA Office of Research and Development 464
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05717582
What this trial is testing

Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment

Who this might be right for
Metastatic Prostate CancerCastration-Sensitive Prostate Cancer
Fudan University 47
Large-scale testing (Phase 3)Looking for participantsNCT04916613
What this trial is testing

ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

Who this might be right for
Prostate Cancer Metastatic
UNICANCER 300
Early research (Phase 1)Study completedNCT04702737
What this trial is testing

AMG 757 in Participants With Neuroendocrine Prostate Cancer

Who this might be right for
Neuroendocrine Prostate Cancer
Amgen 41
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableTemporarily pausedNCT07146113
What this trial is testing

Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

Who this might be right for
Prostate Cancer
AstraZeneca 400
Not applicableLooking for participantsNCT07406282
What this trial is testing

Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

Who this might be right for
Prostatic NeoplasmsMetastatic Hormone-Sensitive Prostate Cancer
Bayer 1,400
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)Active Not RecruitingNCT05288166
What this trial is testing

Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

Who this might be right for
Prostatic NeoplasmsNeoplasm MetastasisUrogenital Neoplasms+14 more
Eli Lilly and Company 925
Not applicableStudy completedNCT00899665
What this trial is testing

Proteases in Patients With Prostate Cancer That Has Spread to the Bone

Who this might be right for
AnemiaMetastatic CancerMyelodysplastic Syndromes+2 more
Barbara Ann Karmanos Cancer Institute 31
Not applicableLooking for participantsNCT06306612
What this trial is testing

CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer

Who this might be right for
Prostate Cancer
RenJi Hospital 192
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Large-scale testing (Phase 3)Not Yet RecruitingNCT07591467
What this trial is testing

Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer

Who this might be right for
BRCA-MutatedNeuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate CancerProstate Cancer
Gustave Roussy, Cancer Campus, Grand Paris 330